Financials

  • Market Capitalization 44.2176 B
  • Employee 883
  • Founded 2014
  • CEO N/A
  • Website www.revmed.com
  • Headquarter Delaware, United States
  • FIGI BBG00829F4P8
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.16
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
6356
ADAP
Adaptimmune Therapeutics plc - American Depositary Shares
0.05 USD0.00%0.00%-61.54%-28.57%0 USD
6359
AADI
Aadi Bioscience Inc
2.05 USD0.00%0.00%-19.29%-27.30%0 USD
6702
NAMSW
NewAmsterdam Pharma Company N.V. - Warrant
16.5100 USD0.00%0.00%-8.28%+30.31%3.20 B USD
6799
DRTSW
Alpha Tau Medical Ltd. - Warrant
3.9000 USD-2.50%-3.94%+59.18%+1460.00%1.28 B USD